Trading Volumes in June Lower Across Most Venues, Year-Over Year and
Month-Over-Month
European Cash Trading Volumes in June Up 10% vs. Prior Year; Up 4%
vs. May
Second Quarter 2012 Trading Volumes Mostly Higher Versus Weak First
Quarter 2012 Levels
NEW YORK--(BUSINESS WIRE)--Jul. 11, 2012--
NYSE Euronext (NYX) today announced trading volumes for its global
derivatives and cash equities exchanges for June 20121.
Trading volumes in June 2012 were mostly down year-over-year and
month-over-month with the exception of European cash trading, which
increased 9.9% compared to the prior year and increased 3.5% compared to
May 2012. For the second quarter, trading volumes increased from weak
first quarter 2012 levels.
Highlights
-
NYSE Euronext global derivatives ADV in June 2012 of 8.3 million
contracts decreased 5.9% compared to June 2011 and decreased 10.6%
from May 2012 levels.
-
NYSE Euronext European derivatives products ADV in June 2012 of 4.6
million contracts decreased 0.8% compared to June 2011 and decreased
8.5% from May 2012. Excluding Bclear, NYSE Liffe's trade
administration and clearing service for OTC products, European
derivatives products ADV decreased 11.6% compared to June 2011 and
decreased 4.8% from May 2012 levels.
-
NYSE Euronext U.S. equity options ADV of 3.6 million contracts in June
2012 decreased 11.7% compared to June 2011 levels and decreased 13.8%
from May 2012. NYSE Euronext’s U.S. options exchanges accounted for
25.6% of total U.S. consolidated equity options trading in June 2012,
down from 26.4% in June 2011 and down from 26.7% in May 2012.
-
NYSE Liffe U.S. ADV of approximately 90,900 contracts decreased from
97,500 contracts in June 2011, but increased from 68,300 contracts in
May 2012.
-
NYSE Euronext European cash products ADV of 1.7 million transactions
in June 2012 increased 9.9% compared to June 2011 and increased 3.5%
from May 2012 levels.
-
NYSE Euronext U.S. cash products handled ADV of 1.8 billion shares in
June 2012 decreased 14.7% compared to June 2011 and decreased 2.8%
compared to May 2012. NYSE Euronext’s Tape A matched market share in
June 2012 was 32.3%, down from 36.6% in June 2011, but up from 31.9%
in May 2012.
-
The preliminary average net revenue per transaction type (as defined
below) for each of the primary trading venues in the second quarter of
2012 is included below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary
|
|
|
Trading Venue
|
4Q11
|
|
|
|
1Q12
|
|
|
|
2Q12
|
|
|
European Derivatives (ex. Bclear)1
|
$0.698
|
|
|
|
$0.659
|
|
|
|
$0.67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Derivatives2
|
$0.148
|
|
|
|
$0.148
|
|
|
|
$0.15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Cash3
|
$0.582
|
|
|
|
$0.573
|
|
|
|
$0.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Cash4
|
$0.039
|
|
|
|
$0.043
|
|
|
|
$0.042
|
|
|
1 Average net revenue per contract, excluding
Bclear.
|
|
|
|
|
|
|
|
|
|
|
2 Average net revenue per contract. Excludes
NYSE Liffe U.S. trading volume.
|
|
|
3 Average net revenue per transaction.
|
|
|
|
|
|
|
|
|
|
|
|
4 Average net revenue per 100 shares handled.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives Trading
European Derivatives
-
NYSE Euronext European derivatives products ADV in June 2012 of 4.6
million contracts decreased 0.8% compared to June 2011 and decreased
8.5% from May 2012 levels.
-
The 4.6 million in European derivatives futures and options contracts
ADV in June 2012 consisted of 2.9 million contracts executed through
our full-service LIFFE CONNECT trading platform and 1.7 million
contracts, or 37.3%, executed through Bclear, NYSE Liffe's trade
administration and clearing service for OTC products. Excluding
Bclear, NYSE Liffe's trade administration and clearing service for OTC
products, European derivatives products ADV decreased 11.6% compared
to June 2011 and decreased 4.8% compared to May 2012.
-
In the second quarter of 2012, European derivatives products ADV of
4.7 million contracts was 12.1% below prior year levels. The 4.7
million in futures and options contracts ADV in the second quarter of
2012 consisted of 2.9 million contracts executed through LIFFE CONNECT
trading platform and 1.7 million contracts, or 37.5%, executed through
Bclear.
-
Year-to-date, European derivatives products ADV of 4.0 million
contracts was 19.7% below prior year levels. The 4.0 million in
futures and options contracts ADV year-to-date consisted of 2.8
million contracts executed through LIFFE CONNECT trading platform and
1.2 million contracts, or 30.1%, executed through Bclear.
-
Total fixed income products ADV of 1.9 million contracts in June 2012
decreased 11.1% from June 2011 and decreased 9.0% from May 2012. In
the second quarter of 2012, total fixed income products ADV of 2.0
million contracts was 9.0% below prior year levels. Year-to-date,
total fixed income products ADV of 1.9 million contracts was 23.2%
below prior year levels.
-
Total equity products (including Bclear) ADV of 2.6 million contracts
in June 2012 increased 9.0% compared to June 2011, but decreased 8.6%
from May 2012. The 2.6 million contracts in equity products ADV in
June 2012 consisted of 2.0 million contracts in individual equity
products ADV and 0.6 million contracts in equity index products ADV.
The 2.0 million contracts in individual equity products ADV consisted
of 1.5 million in futures contracts, which represented a 29.8%
increase compared to June 2011 and 0.5 million in options contracts,
which represented a 16.6% decrease compared to June 2011. The average
net rate per contract for individual equity futures contracts is
significantly lower than other European derivatives products. In the
second quarter of 2012, total equity products ADV of 2.6 million
contracts were 14.4% below prior year levels. Year-to-date, total
equity products ADV of 2.0 million contracts was 16.7% below prior
year levels.
-
Total commodities products ADV of approximately 82,000 contracts in
June 2012 decreased 12.6% compared to June 2011, but increased 11.3%
compared to May 2012. In the second quarter of 2012, total commodities
product ADV of 78,000 contracts was 7.1% below prior year levels. Year-to-date,
total commodities product ADV of 80,000 contracts was 7.2% below prior
year levels.
U.S. Derivatives
-
NYSE Euronext U.S. equity options ADV of 3.6 million contracts in June
2012 decreased 11.7% compared to June 2011 and decreased 13.8%
compared to May 2012. In the second quarter of 2012, U.S. equity
options ADV of 3.9 million contracts was 3.4% below prior year levels.
Year-to-date, U.S. equity options ADV of 4.0 million contracts was
5.0% below prior year levels.
-
Total U.S. consolidated equity options ADV decreased 8.9% to 14.2
million contracts in June 2012 compared to June 2011 and decreased
9.9% compared to May 2012. In the second quarter of 2012, U.S.
consolidated equity options ADV of 14.9 million contracts was 5.4%
below prior year levels. Year-to-date, U.S. consolidated equity
options ADV of 15.4 million contracts was 6.9% below prior year levels.
-
NYSE Euronext’s U.S. options exchanges accounted for 25.6% of total
U.S. consolidated equity options trading in June 2012, down from 26.4%
in June 2011 and down from 26.7% in May 2012.
-
NYSE Liffe U.S. ADV of approximately 90,900 contracts decreased from
97,500 contracts in June 2011, but increased from 68,500 contracts in
May 2012. In the second quarter of 2012, U.S. futures and futures
options ADV of 73,400 contracts was 21.5% below prior year levels.
Year-to-date, U.S. futures and futures options ADV of 84,700 contracts
was 48.1% above prior year levels.
Cash Trading
European Cash
-
NYSE Euronext European cash products ADV of 1.7 million transactions
in June 2012 increased 9.9% compared to June 2011 and increased 3.5%
compared to May 2012.
-
In the second quarter of 2012, European cash products ADV of 1.7
million transactions was 11.0% above prior year levels.
-
Year-to-date, European cash products ADV of 1.6 million transactions
was 1.7% below prior year levels.
U.S. Cash
-
NYSE Euronext U.S. cash products handled ADV in June 2012 decreased
14.7% to 1.8 billion shares compared to June 2011 and decreased 2.8%
from May 2012.
-
In the second quarter of 2012, U.S. cash products handled ADV was 1.8
billion shares, down 12.3% from prior year levels.
-
Year-to-date, U.S. cash products handled ADV was 1.8 billion shares,
down 17.8% from prior year levels.
-
NYSE Euronext’s Tape A matched market share in June 2012 was 32.3%,
down from 36.6% in June 2011, but up from 31.9% in May 2012.
Exchange Traded Funds
-
NYSE Euronext U.S. matched exchange-traded funds ADV (included in
volumes for Tape B and Tape C) of 245 million shares in June 2012
decreased 16.2% compared to June 2011 and decreased 2.6% compared to
May 2012.
-
In the second quarter of 2012, NYSE Euronext U.S. matched
exchange-traded funds ADV of 238 million shares was 14.2% below prior
year levels.
-
Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of
230 million shares was 18.0% below prior year levels.
Other Metrics
-
The wind-down of NYSE Blue completed in April 2012 will lower
quarterly revenue (other revenue) by $4 million and lower costs by $5
million beginning in the second quarter of 2012.
-
The non-GAAP effective tax rate for the second quarter of 2012 is
anticipated to be 25%.
-
The loss attributable to NYSE Euronext’s non-controlling interest in
the NYSE Liffe U.S. is anticipated to be lower in the second quarter
of 2012 as a result of cost control efforts.
-
During the second quarter of 2012, a total of 6.9 million shares were
repurchased at an average price of $25.60. The current $552 million
stock repurchase authorization has $248 million remaining as of June
30, 2012. As a result of these repurchases, the weighted average
diluted shares outstanding in the second quarter was 253 million
shares.
-
The average EUR/USD exchange rate for the second quarter of 2012 of
$1.28 represented a decrease of 2.1% from the first quarter of 2012
and a decrease of 10.8% compared to the second quarter of 2011. The
average GBP/USD exchange rate for the second quarter of 2012 of $1.58
represented an increase of 0.7% from the first quarter of 2012 and a
decrease of 3.0% compared to the second quarter of 2011.
Please click
here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets
and provider of innovative trading technologies. The company's exchanges
in Europe and the United States trade equities, futures, options,
fixed-income and exchange-traded products. With approximately 8,000
listed issues (excluding European Structured Products), NYSE Euronext's
equities markets – the New York Stock Exchange, NYSE Euronext, NYSE
Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's
equities trading, the most liquidity of any global exchange group. NYSE
Euronext also operates NYSE Liffe, one of the leading European
derivatives businesses and the world's second-largest derivatives
business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and
services through NYSE Technologies. NYSE Euronext is in the S&P 500
index, and is the only exchange operator in the Fortune 500. For more
information, please visit: http://www.nyx.com.
Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include,
but are not limited to, statements concerning NYSE Euronext's plans,
objectives, expectations and intentions and other statements that are
not historical or current facts. Forward-looking statements are based on
NYSE Euronext's current expectations and involve risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied in such forward-looking statements. Factors that
could cause NYSE Euronext's results to differ materially from current
expectations include, but are not limited to: NYSE Euronext's ability to
implement its strategic initiatives, economic, political and market
conditions and fluctuations, government and industry regulation,
interest rate risk and U.S. and global competition, and other factors
detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other
periodic reports filed with the U.S. Securities and Exchange Commission
or the French Autorité des Marchés Financiers. In addition, these
statements are based on a number of assumptions that are subject to
change. Accordingly, actual results may be materially higher or lower
than those projected. The inclusion of such projections herein should
not be regarded as a representation by NYSE Euronext that the
projections will prove to be correct. This press release speaks only as
of this date. NYSE Euronext disclaims any duty to update the information
herein.
1 All NYSE Euronext derivatives transactions count buy and
sell orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy and
sell orders together as a single transaction.
|
NYSE Euronext
|
|
Monthly Volume Summary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Daily Volume
|
|
|
Total Volume
|
|
|
|
Average
Daily Volume
|
|
|
Total Volume
|
|
(Unaudited; contracts in thousands)
|
|
Jun-12
|
|
Jun-11
|
|
% Chg
|
|
|
Jun-12
|
|
Jun-11
|
|
% Chg
|
|
|
YTD 2012
|
|
% Chg vs.
YTD
2011
|
|
|
YTD 2012
|
|
% Chg
vs.
YTD
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Trading Days - European Cash
|
|
|
21
|
|
22
|
|
|
|
|
|
21
|
|
22
|
|
|
|
|
|
127
|
|
|
|
|
|
127
|
|
|
|
Number of Trading Days - European Derivatives
|
|
|
21
|
|
22
|
|
|
|
|
|
21
|
|
22
|
|
|
|
|
|
128
|
|
|
|
|
|
128
|
|
|
|
Number of Trading Days - U.S. Markets
|
|
|
|
21
|
|
22
|
|
|
|
|
|
21
|
|
22
|
|
|
|
|
|
125
|
|
|
|
|
|
125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Derivatives Products
|
|
|
|
|
4,597
|
|
4,634
|
|
-0.8%
|
|
|
|
96,544
|
|
101,957
|
|
-5.3%
|
|
|
|
3,983
|
|
-19.7%
|
|
|
|
509,777
|
|
-19.1%
|
|
of which Bclear
|
|
|
|
|
1,714
|
|
1,373
|
|
24.8%
|
|
|
|
35,998
|
|
30,217
|
|
19.1%
|
|
|
|
1,200
|
|
-16.8%
|
|
|
|
153,556
|
|
-16.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fixed Income Products
|
|
|
|
|
1,924
|
|
2,163
|
|
-11.1%
|
|
|
|
40,401
|
|
47,583
|
|
-15.1%
|
|
|
|
1,862
|
|
-23.2%
|
|
|
|
238,387
|
|
-22.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short Term Interest Rate Products
|
|
|
|
|
1,783
|
|
2,025
|
|
-11.9%
|
|
|
|
37,451
|
|
44,540
|
|
-15.9%
|
|
|
|
1,710
|
|
-25.3%
|
|
|
|
218,917
|
|
-24.7%
|
|
Medium and Long Term Interest Rate Products 1
|
|
|
140
|
|
138
|
|
1.6%
|
|
|
|
2,950
|
|
3,043
|
|
-3.0%
|
|
|
|
152
|
|
11.6%
|
|
|
|
19,469
|
|
12.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Equity Products 2
|
|
|
|
|
2,592
|
|
2,378
|
|
9.0%
|
|
|
|
54,432
|
|
52,322
|
|
4.0%
|
|
|
|
2,040
|
|
-16.7%
|
|
|
|
261,162
|
|
-16.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual Equity Products
|
|
|
|
|
2,005
|
|
1,754
|
|
14.3%
|
|
|
|
42,111
|
|
38,582
|
|
9.1%
|
|
|
|
1,534
|
|
-19.1%
|
|
|
|
196,328
|
|
-18.4%
|
|
Futures
|
|
|
|
|
1,517
|
|
1,168
|
|
29.8%
|
|
|
|
31,854
|
|
25,702
|
|
23.9%
|
|
|
|
1,048
|
|
-17.7%
|
|
|
|
134,137
|
|
-17.1%
|
|
Options
|
|
|
|
|
488
|
|
585
|
|
-16.6%
|
|
|
|
10,257
|
|
12,880
|
|
-20.4%
|
|
|
|
486
|
|
-21.9%
|
|
|
|
62,191
|
|
-21.2%
|
|
Equity Index Products
|
|
|
|
|
587
|
|
625
|
|
-6.1%
|
|
|
|
12,321
|
|
13,741
|
|
-10.3%
|
|
|
|
507
|
|
-8.6%
|
|
|
|
64,834
|
|
-7.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of which Bclear
|
|
|
|
|
1,714
|
|
1,373
|
|
24.8%
|
|
|
|
35,998
|
|
30,217
|
|
19.1%
|
|
|
|
1,200
|
|
-16.8%
|
|
|
|
153,556
|
|
-16.2%
|
|
Individual Equity Products
|
|
|
|
|
1,621
|
|
1,263
|
|
28.4%
|
|
|
|
34,044
|
|
27,776
|
|
22.6%
|
|
|
|
1,125
|
|
-17.6%
|
|
|
|
144,023
|
|
-17.0%
|
|
Futures
|
|
|
|
|
1,512
|
|
1,168
|
|
29.5%
|
|
|
|
31,759
|
|
25,696
|
|
23.6%
|
|
|
|
1,023
|
|
-18.7%
|
|
|
|
130,972
|
|
-18.1%
|
|
Options
|
|
|
|
|
109
|
|
95
|
|
15.0%
|
|
|
|
2,284
|
|
2,080
|
|
9.8%
|
|
|
|
102
|
|
-4.9%
|
|
|
|
13,051
|
|
-4.1%
|
|
Equity Index Products
|
|
|
|
|
93
|
|
111
|
|
-16.1%
|
|
|
|
1,955
|
|
2,441
|
|
-19.9%
|
|
|
|
74
|
|
-2.8%
|
|
|
|
9,533
|
|
-2.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity Products
|
|
|
|
|
82
|
|
93
|
|
-12.6%
|
|
|
|
1,712
|
|
2,051
|
|
-16.6%
|
|
|
|
80
|
|
-7.2%
|
|
|
|
10,228
|
|
-6.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Derivatives Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Options 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Euronext Options Contracts
|
|
|
|
|
3,624
|
|
4,105
|
|
-11.7%
|
|
|
|
76,103
|
|
90,301
|
|
-15.7%
|
|
|
|
4,020
|
|
-5.0%
|
|
|
|
502,556
|
|
-5.0%
|
|
Total Consolidated Options Contracts
|
|
|
|
|
14,183
|
|
15,570
|
|
-8.9%
|
|
|
|
297,841
|
|
342,531
|
|
-13.0%
|
|
|
|
15,391
|
|
-6.9%
|
|
|
|
1,923,930
|
|
-6.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Group Share of Total
|
|
|
|
|
25.6%
|
|
26.4%
|
|
|
|
|
|
25.6%
|
|
26.4%
|
|
|
|
|
|
26.1%
|
|
0.5%
|
|
|
|
26.1%
|
|
0.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Liffe U.S.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures and Futures Options Volume*
|
|
|
|
|
90.9
|
|
97.5
|
|
-6.8%
|
|
|
|
1,908
|
|
2,145
|
|
-11.1%
|
|
|
|
84.7
|
|
48.1%
|
|
|
|
10,930.6
|
|
49.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Cash Products (trades in thousands)
|
|
|
|
|
1,668
|
|
1,518
|
|
9.9%
|
|
|
|
35,034
|
|
33,396
|
|
4.9%
|
|
|
|
1,645
|
|
-1.7%
|
|
|
|
208,861
|
|
-1.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities
|
|
|
|
|
1,617
|
|
1,461
|
|
10.7%
|
|
|
|
33,966
|
|
32,146
|
|
5.7%
|
|
|
|
1,591
|
|
-1.0%
|
|
|
|
202,107
|
|
-1.0%
|
|
Exchange-Traded Funds
|
|
|
|
|
14
|
|
17
|
|
-20.4%
|
|
|
|
287
|
|
377
|
|
-24.0%
|
|
|
|
14
|
|
-22.0%
|
|
|
|
1,831
|
|
-22.0%
|
|
Structured Products
|
|
|
|
|
32
|
|
35
|
|
-8.5%
|
|
|
|
668
|
|
765
|
|
-12.7%
|
|
|
|
34
|
|
-16.9%
|
|
|
|
4,294
|
|
-16.9%
|
|
Bonds
|
|
|
|
|
|
5
|
|
5
|
|
10.6%
|
|
|
|
114
|
|
108
|
|
5.6%
|
|
|
|
5
|
|
-5.9%
|
|
|
|
628
|
|
-5.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Cash Products (shares in millions) 5
|
|
|
|
|
1,837
|
|
2,153
|
|
-14.7%
|
|
|
|
38,580
|
|
47,362
|
|
-18.5%
|
|
|
|
1,801
|
|
-17.8%
|
|
|
|
225,100
|
|
-17.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Listed (Tape A) Issues 4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
1,323
|
|
1,525
|
|
-13.3%
|
|
|
|
27,782
|
|
33,556
|
|
-17.2%
|
|
|
|
1,287
|
|
-17.7%
|
|
|
|
160,922
|
|
-17.7%
|
|
Matched Volume 6
|
|
|
|
|
1,264
|
|
1,450
|
|
-12.8%
|
|
|
|
26,554
|
|
31,902
|
|
-16.8%
|
|
|
|
1,219
|
|
-17.7%
|
|
|
|
152,355
|
|
-17.7%
|
|
Total NYSE Listed Consolidated Volume
|
|
|
|
|
3,918
|
|
3,961
|
|
-1.1%
|
|
|
|
82,268
|
|
87,140
|
|
-5.6%
|
|
|
|
3,906
|
|
-8.1%
|
|
|
|
488,298
|
|
-8.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
33.8%
|
|
38.5%
|
|
-4.7%
|
|
|
|
33.8%
|
|
38.5%
|
|
-4.7%
|
|
|
|
33.0%
|
|
-3.8%
|
|
|
|
33.0%
|
|
-3.8%
|
|
Matched Volume 6
|
|
|
|
|
32.3%
|
|
36.6%
|
|
-4.3%
|
|
|
|
32.3%
|
|
36.6%
|
|
-4.3%
|
|
|
|
31.2%
|
|
-3.6%
|
|
|
|
31.2%
|
|
-3.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Arca, MKT and Regional (Tape B) Listed
Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
288
|
|
354
|
|
-18.6%
|
|
|
|
6,046
|
|
7,779
|
|
-22.3%
|
|
|
|
272
|
|
-20.2%
|
|
|
|
33,960
|
|
-20.2%
|
|
Matched Volume 6
|
|
|
|
|
261
|
|
320
|
|
-18.4%
|
|
|
|
5,478
|
|
7,032
|
|
-22.1%
|
|
|
|
243
|
|
-20.4%
|
|
|
|
30,433
|
|
-20.4%
|
|
Total NYSE Arca & MKT Listed Consolidated Volume
|
|
|
|
|
1,212
|
|
1,347
|
|
-10.0%
|
|
|
|
25,443
|
|
29,629
|
|
-14.1%
|
|
|
|
1,155
|
|
-12.4%
|
|
|
|
144,402
|
|
-12.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
23.8%
|
|
26.3%
|
|
-2.5%
|
|
|
|
23.8%
|
|
26.3%
|
|
-2.5%
|
|
|
|
23.5%
|
|
-2.3%
|
|
|
|
23.5%
|
|
-2.3%
|
|
Matched Volume 6
|
|
|
|
|
21.5%
|
|
23.7%
|
|
-2.2%
|
|
|
|
21.5%
|
|
23.7%
|
|
-2.2%
|
|
|
|
21.1%
|
|
-2.1%
|
|
|
|
21.1%
|
|
-2.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nasdaq Listed (Tape C) Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
226
|
|
274
|
|
-17.4%
|
|
|
|
4,752
|
|
6,026
|
|
-21.1%
|
|
|
|
242
|
|
-15.8%
|
|
|
|
30,218
|
|
-15.8%
|
|
Matched Volume 6
|
|
|
|
|
196
|
|
233
|
|
-16.1%
|
|
|
|
4,109
|
|
5,131
|
|
-19.9%
|
|
|
|
206
|
|
-15.6%
|
|
|
|
25,726
|
|
-15.6%
|
|
Total Nasdaq Listed Consolidated Volume
|
|
|
|
|
1,790
|
|
2,021
|
|
-11.4%
|
|
|
|
37,595
|
|
44,468
|
|
-15.5%
|
|
|
|
1,799
|
|
-11.1%
|
|
|
|
224,885
|
|
-11.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
12.6%
|
|
13.6%
|
|
-1.0%
|
|
|
|
12.6%
|
|
13.6%
|
|
-1.0%
|
|
|
|
13.4%
|
|
-0.8%
|
|
|
|
13.4%
|
|
-0.8%
|
|
Matched Volume 6
|
|
|
|
|
10.9%
|
|
11.5%
|
|
-0.6%
|
|
|
|
10.9%
|
|
11.5%
|
|
-0.6%
|
|
|
|
11.4%
|
|
-0.7%
|
|
|
|
11.4%
|
|
-0.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-Traded Funds 5,7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
271
|
|
324
|
|
-16.6%
|
|
|
|
5,684
|
|
7,137
|
|
-20.4%
|
|
|
|
257
|
|
-17.7%
|
|
|
|
32,100
|
|
-17.7%
|
|
Matched Volume 6
|
|
|
|
|
245
|
|
292
|
|
-16.2%
|
|
|
|
5,140
|
|
6,426
|
|
-20.0%
|
|
|
|
230
|
|
-18.0%
|
|
|
|
28,714
|
|
-18.0%
|
|
Total ETF Consolidated Volume
|
|
|
|
|
1,181
|
|
1,278
|
|
-7.6%
|
|
|
|
24,792
|
|
28,111
|
|
-11.8%
|
|
|
|
1,126
|
|
-8.3%
|
|
|
|
140,693
|
|
-8.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
|
|
|
22.9%
|
|
25.4%
|
|
-2.5%
|
|
|
|
22.9%
|
|
25.4%
|
|
-2.5%
|
|
|
|
22.8%
|
|
-2.6%
|
|
|
|
22.8%
|
|
-2.6%
|
|
Matched Volume 6
|
|
|
|
|
20.7%
|
|
22.9%
|
|
-2.2%
|
|
|
|
20.7%
|
|
22.9%
|
|
-2.2%
|
|
|
|
20.4%
|
|
-2.4%
|
|
|
|
20.4%
|
|
-2.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Data includes currency products.
|
|
2 Includes all trading activities for Bclear, NYSE
Liffe's clearing service for wholesale derivatives.
|
|
|
|
|
|
|
|
3 Includes trading in U.S. equity
options contracts, not equity-index options.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 Includes all volume executed in NYSE
Group crossing sessions.
|
|
|
|
|
|
|
|
5 Represents the total number of
shares of equity securities and ETFs internally matched on the
NYSE Group's exchanges or routed to and
executed at an external market center. NYSE Arca routing
includes odd-lots.
|
|
6 Represents the total number of
shares of equity securities and ETFs executed on the NYSE Group's
exchanges.
|
|
7 Data included in previously
identified categories.
|
|
* ADVs calculated with the appropriate
number of NYSE Liffe U.S. trading days.
|
|
|
|
|
|
|
|
|
|
|
|
|
Source: NYSE Euronext, Options Clearing Corporation and
Consolidated Tape as reported for equity securities.
|
|
All trading activity is single-counted, except European cash
trading which is double counted to include both buys and sells.
|
Source: NYSE Euronext
NYSE Euronext
Investor Relations:
+1.212.656.5700 (New York)
+33.1.49.27.58.60
(Paris)
or
Media:
+31.20.550.4488 (Amsterdam)
+32.2.509.1392
(Brussels)
+351.217.900.029 (Lisbon)
+44.20.7379.2789 (London)
+1.212.656.2411
(New York)
+33.1.49.27.11.33 (Paris)